000			01700 a2200493 4500
005			20250513142142.0
264		0	_c19980513
008			199805s 0 0 eng d
022			_a0950-9232
024	7		_a10.1038/sj.onc.1201667 _2doi
040			_aNLM _beng _cNLM
100	1		_aHiyama, H
245	0	0	_aRegulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. _h[electronic resource]
260			_bOncogene _cMar 1998
300			_a1513-23 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBinding Sites _xgenetics
650	0	4	_aCarrier Proteins
650	0	4	_aCell Cycle _xgenetics
650	0	4	_aCell Cycle Proteins
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21
650	0	4	_aCyclins _xgenetics
650	0	4	_aDNA-Binding Proteins
650	0	4	_aE2F Transcription Factors
650	0	4	_aE2F1 Transcription Factor
650	0	4	_aE2F4 Transcription Factor
650	0	4	_aEnzyme Inhibitors _xmetabolism
650	0	4	_aG1 Phase _xgenetics
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGlioma
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aPromoter Regions, Genetic _xgenetics
650	0	4	_aRetinoblastoma-Binding Protein 1
650	0	4	_aS Phase _xgenetics
650	0	4	_aTranscription Factor DP1
650	0	4	_aTranscription Factors _xmetabolism
650	0	4	_aTumor Cells, Cultured
700	1		_aIavarone, A
700	1		_aReeves, S A
773	0		_tOncogene _gvol. 16 _gno. 12 _gp. 1513-23
856	4	0	_uhttps://doi.org/10.1038/sj.onc.1201667 _zAvailable from publisher's website
999			_c9536063 _d9536063